PhoreMost's Series A Round

PhoreMost raised a round of funding on May 15, 2018.

PhoreMost has developed a next-generation phenotypic screening platform called 'Site-Seeker' to identify the best new targets for future therapy, and crucially, how to drug them. This has the potentia…

Articles about PhoreMost's Series A Round: